Skip to Main Content
Skip Nav Destination

Issue Archive

54th ASH® Annual Meeting and Exposition

Ham-Wasserman Lecture

3 P’s in a Pod

Acute Myeloid Leukemia: Newly Discovered Genes, Screens (for Minimal Residual Disease), and Therapeutic Means

Advances in the Pathogenesis and Treatment of Myelodysplastic Syndromes

Chronic Lymphocytic Leukemia: Can New Prognostic Factors Guide New Therapeutic Approaches?

Chronic Myeloid Leukemia: The Pristine Paradigm for Successful Targeted Therapy

Dynamic Discoveries and Directions in Pediatric Leukemias

Everyday Bleeding Disorders

Evidence-Based Approaches to Cytopenias

Hematologic Diseases in Pregnancy

Hematopoietic Stem Cell Transplantation I: Exploiting Alternative Donors

Hematopoietic Stem Cell Transplantation II: Toward Safer Allogeneic Transplantation

Hemoglobinopathies: New Frontiers and Insights

Immune Dysregulation

Insights into Biology and Refinement of Treatment Strategies in Hodgkin Lymphoma

Keeping Pace with Advances in Myeloma

Landscape Changes and Challenges in Hemophilia

New Insights into the Genetic Pathogenesis of Acute Lymphocytic Leukemia and New Treatment Strategies

Non-Hodgkin Lymphoma I: Changing Therapeutic Strategies in Aggressive Lymphomas

Non-Hodgkin Lymphoma II: Understanding the Indolent Lymphomas

Not So ‘Benign’ Hematologic Issues in Children

Pearls and Pitfalls in the Hematology Lab: Clotting and Bleeding

Pearls and Pitfalls in the Hematology Lab: Updates on Cellular Diagnostics

Pediatric Issues in Platelet Transfusions

Perioperative Hematology: To Bleed or Not To Bleed

The New Era in Antithrombotic Therapy

The Spectrum of JAK2-Positive Myeloproliferative Neoplasms: Complications and Therapeutic Advances

The Spectrum of Plasma Cell Dyscrasias

The Thrombotic Thrombocytopenic Purpura and Hemolytic Uremic Syndromes: New Insights and New Treatments

Thrombosis in Challenging Populations

Untangling Uncommon Lymphoproliferative Disorders


Close Modal

or Create an Account

Close Modal
Close Modal